Quigley, Eamonn M.M. (2013). „Treatment level 1”. Irritable bowel syndrome : diagnosis and clinical management (First изд.). Chichester, West Sussex: Wiley-Blackwell. ISBN978-1-118-44474-0. Архивирано из оригинала 8. 9. 2017. г.
doi.org
Chey WD, Kurlander J, Eswaran S (март 2015). „Irritable bowel syndrome: a clinical review”. JAMA. 313 (9): 949—58. PMID25734736. doi:10.1001/jama.2015.0954.
Levy J, Bernstein L, Silber N (децембар 2014). „Celiac disease: an immune dysregulation syndrome”. Current Problems in Pediatric and Adolescent Health Care. 44 (11): 324—7. PMID25499458. doi:10.1016/j.cppeds.2014.10.002.
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R (2006). „Costs of irritable bowel syndrome in the UK and US”. PharmacoEconomics. 24 (1): 21—37. PMID16445300. doi:10.2165/00019053-200624010-00002.
Chey WD, Kurlander J, Eswaran S (март 2015). „Irritable bowel syndrome: a clinical review”. JAMA. 313 (9): 949—58. PMID25734736. doi:10.1001/jama.2015.0954.
Levy J, Bernstein L, Silber N (децембар 2014). „Celiac disease: an immune dysregulation syndrome”. Current Problems in Pediatric and Adolescent Health Care. 44 (11): 324—7. PMID25499458. doi:10.1016/j.cppeds.2014.10.002.
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R (2006). „Costs of irritable bowel syndrome in the UK and US”. PharmacoEconomics. 24 (1): 21—37. PMID16445300. doi:10.2165/00019053-200624010-00002.